Trial Profile
A PLACEBO-CONTROLLED RANDOMIZED WITHDRAWAL EVALUATION OF THE EFFICACY AND SAFETY OF BACLOFEN ER CAPSULES (GRS) IN SUBJECTS WITH SPASTICITY DUE TO MULTIPLE SCLEROSIS
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Jun 2019
Price :
$35
*
At a glance
- Drugs Baclofen (Primary)
- Indications Muscle spasticity
- Focus Registrational; Therapeutic Use
- Sponsors Sun Pharma Advanced Research Company
- 16 Jun 2019 Status changed from active, no longer recruiting to completed.
- 02 Feb 2018 Planned End Date changed from 1 Aug 2017 to 1 Mar 2018.
- 11 Oct 2017 This trial has been completed in Hungary, according to European Clinical Trials Database